Roche Pharma Copegus

Copegus is used in the treatment of hepatitis c and belongs to the drug classes inhaled anti-infectives, purine nucleosides. Copegus is indicated for the treatment of chronic hepatitis C and must only be used as part of a combination regimen with peginterferon alfa-2a or with interferon alfa-2a.

read more
technical specification